Abstract

BackgroundDental pulp stem cells (DPSCs) are increasingly being advocated as viable cell sources for regenerative medicine-based therapies. However, significant heterogeneity in DPSC expansion and multi-potency capabilities are well-established, attributed to contrasting telomere profiles and susceptibilities to replicative senescence. As DPSCs possess negligible human telomerase (hTERT) expression, we examined whether intrinsic differences in the susceptibilities of DPSC sub-populations to oxidative stress-induced biomolecular damage and premature senescence further contributed to this heterogeneity, via differential enzymic antioxidant capabilities between DPSCs.MethodsDPSCs were isolated from human third molars by differential fibronectin adhesion, and positive mesenchymal (CD73/CD90/CD105) and negative hematopoietic (CD45) stem cell marker expression confirmed. Isolated sub-populations were expanded in H2O2 (0–200 μM) and established as high or low proliferative DPSCs, based on population doublings (PDs) and senescence (telomere lengths, SA-β-galactosidase, p53/p16INK4a/p21waf1/hTERT) marker detection. The impact of DPSC expansion on mesenchymal, embryonic, and neural crest marker expression was assessed, as were the susceptibilities of high and low proliferative DPSCs to oxidative DNA and protein damage by immunocytochemistry. Expression profiles for superoxide dismutases (SODs), catalase, and glutathione-related antioxidants were further compared between DPSC sub-populations by qRT-PCR, Western blotting and activity assays.ResultsHigh proliferative DPSCs underwent > 80PDs in culture and resisted H2O2−induced senescence (50–76PDs). In contrast, low proliferative sub-populations exhibited accelerated senescence (4–32PDs), even in untreated controls (11-34PDs). While telomere lengths were largely unaffected, certain stem cell marker expression declined with H2O2 treatment and expansion. Elevated senescence susceptibilities in low proliferative DPSC (2–10PDs) were accompanied by increased oxidative damage, absent in high proliferative DPSCs until 45–60PDs. Increased SOD2/glutathione S-transferase ζ1 (GSTZ1) expression and SOD activities were identified in high proliferative DPSCs (10–25PDs), which declined during expansion. Low proliferative DPSCs (2–10PDs) exhibited inferior SOD, catalase and glutathione-related antioxidant expression/activities.ConclusionsSignificant variations exist in the susceptibilities of DPSC sub-populations to oxidative damage and premature senescence, contributed to by differential SOD2 and GSTZ1 profiles which maintain senescence-resistance/stemness properties in high proliferative DPSCs. Identification of superior antioxidant properties in high proliferative DPSCs enhances our understanding of DPSC biology and senescence, which may be exploited for selective sub-population screening/isolation from dental pulp tissues for regenerative medicine-based applications.

Highlights

  • Dental pulp stem cells (DPSCs) are increasingly being advocated as viable cell sources for regenerative medicine-based therapies

  • Increased SOD2/ glutathione S-transferase ζ1 (GSTZ1) expression and superoxide dismutases (SODs) activities were identified in high proliferative DPSCs (10– 25PDs), which declined during expansion

  • Significant variations exist in the susceptibilities of DPSC sub-populations to oxidative damage and premature senescence, contributed to by differential SOD2 and GSTZ1 profiles which maintain senescenceresistance/stemness properties in high proliferative DPSCs

Read more

Summary

Introduction

Dental pulp stem cells (DPSCs) are increasingly being advocated as viable cell sources for regenerative medicine-based therapies. Such issues are confounded by DPSCs being proposed to exist within distinct niches within dental pulp tissues (subodontoblast layer, pulpal vasculature and central pulp) [7], which increases their complexity regarding the origins and regenerative characteristics of individual DPSC sub-populations Such features have major implications for successful DPSC exploitation, as a significant limitation of mesenchymal stem cell (MSC)-based therapies is the extensive in vitro expansion necessary to produce sufficient cell numbers for clinical use. Cell expansion eventually leads to proliferative decline and replicative (telomere-dependent) senescence, characterized by progressive telomere shortening, inhibition of G1-S phase transition and permanent growth arrest This is associated with the loss of telomeric TTAGGG repeats, positive senescence-associated (SA)-β-galactosidase staining, and increased tumor suppressor (p53 and retinoblastoma protein, pRb) and cyclin-dependent kinase inhibitor (p21waf and p16INK4a) gene expression [8,9,10]. Such events are recognized to significantly alter MSC genotype and phenotype, leading to impaired regenerative properties and disrupted local tissue microenvironment signaling mechanisms, through the secretome associated with the senescence-associated secretory phenotype (SASP) [10, 11]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call